Implantable cardioverter-defibrillator FDA safety advisories: Impact on patient mortality and morbidity

Heart Rhythm

Volumn 9, Issue 10, 2012, Pages 1619-1626

  Sengupta, Jay ^a   Kendig, Arthur C ^a   Goormastic, Marlene ^a   Hwang, Eui Seock ^a   Ching, Elizabeth A ^a   Chung, Roy ^a   Lindsay, Bruce D ^a   Tchou, Patrick J ^a   Wilkoff, Bruce L ^a   Niebauer, Mark J ^a   Martin, David O ^a   Varma, Niraj ^a   Wazni, Oussama ^a   Saliba, Walid ^a   Kanj, Mohamed ^a   Bhargava, Mandeep ^a   Dresing, Thomas ^a   Taigen, Tyler ^a   Ingelmo, Christopher ^a   Bassiouny, Mohamed ^a   Cronin, Edmond M ^a   Wilsmore, Bradley ^a   Rickard, John ^a   Chung, Mina K ^a   more..

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

FDA; Implantable cardioverter defibrillators; mortality; Safety

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN;

ADULT; ARTICLE; CONSERVATIVE TREATMENT; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DEVICE SAFETY; EXPLANT; FEMALE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUDDEN DEATH; SURVIVAL RATE;

ARRHYTHMIAS, CARDIAC; CHI-SQUARE DISTRIBUTION; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; EQUIPMENT FAILURE; FEMALE; HUMANS; MALE; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84866732149     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2012.07.002     Document Type: Article

References (18)

1. S.C. Hammill, M.S. Kremers, L.W. Stevenson Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure Heart Rhythm 7 2010 1340 1345
2. Heart Rhythm Society Proceedings document from the Policy Conference on Pacemaker and ICD Performance http://www.hrsonline.org/advocacyDocs/HRS-device- conference.pdf Accessed January 28, 2006
3. T. Thom, N. Haase, W. Rosamond Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 113 2006 e85 e151
4. W. Rosamond, K. Flegal, G. Friday et al. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee 115 2007 e69 e171
5. J. Kron Clinical significance of device-related complications in clinical trials and implications for future trials: insights from the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial Card Electrophysiol Rev 7 2003 473 478
6. R.G. Hauser, L.M. Kallinen, A.K. Almquist, C.C. Gornick, W.T. Katsiyiannis Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead Heart Rhythm 4 2007 892 896
7. C.D. Swerdlow Small-diameter defibrillation electrodes: can they take a licking and keep hearts ticking? Heart Rhythm 4 2007 900 903
8. A. Messali, O. Thomas, M. Chauvin, P. Coumel, A. Leenhardt Death due to an implantable cardioverter defibrillator J Cardiovasc Electrophysiol 15 2004 953 956
9. W.H. Maisel, M.O. Sweeney, W.G. Stevenson, K.E. Ellison, L.M. Epstein Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators JAMA 286 2001 793 799
10. US Food and Drug Administration FDA releases results of study on defibrillator and pacemaker malfunctions: part of agency drive to improve device safety monitoring and public communications http://www.fda.gov/bbs/topics/NEWS/ 2005/ NEW01231.html Accessed September 17, 2005
11. US Food and Drug Administration FDA recall policies http://vm.cfsan.fda. gov/∼lrd/recall2.html Accessed July 21, 2005
12. W.H. Maisel Pacemaker and ICD generator reliability: meta-analysis of device registries JAMA 295 2006 1929 1934
13. R.G. Hauser, D.L. Hayes, A.E. Epstein Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators Heart Rhythm 3 2006 640 644
14. M.D. Carlson, B.L. Wilkoff, W.H. Maisel Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines Heart Rhythm 3 2006 1250 1273
15. P.A. Gould, A.D. Krahn Canadian Heart Rhythm Society Working Group on Device Advisories Complications associated with implantable cardioverter- defibrillator replacement in response to device advisories JAMA 295 2006 1907 1911
16. J.E. Poole, M.J. Gleva, T. Mela Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry Circulation 122 2010 1553 1561
17. L.J. Gula, D. Massel, A.D. Krahn, A.C. Skanes, R. Yee, G.J. Klein Survival rates as a guide to implanted cardioverter-defibrillator replacement strategies for device recalls - adding statistical insight to clinical intuition Am Heart J 153 2007 253 259
18. B.L. Wilkoff Pacemaker and ICD malfunction - an incomplete picture JAMA 295 2006 1944 1946